Literature DB >> 1573127

Higher alpha 1-antitrypsin, haptoglobin, ceruloplasmin and lower retinol binding protein plasma levels during depression: further evidence for the existence of an inflammatory response during that illness.

M Maes1, S Scharpé, L Van Grootel, W Uyttenbroeck, W Cooreman, P Cosyns, E Suy.   

Abstract

Recently, a few reports have shown that severe depression may be associated with higher levels of positive acute phase proteins (APPs), such as haptoglobin (Hp), alpha 1-acid glycoprotein (alpha 1S) and lower levels of negative APPs (visceral proteins), such as albumin (Alb) and transferrin (Tf). In order to reassess whether depression is related to alterations in the expression of plasma APP concentrations, we measured in 84 normal controls and depressed inpatients positive APPs such as Hp, alpha 1-antitrypsin (alpha 1AT), hemopexin (Hpx), ceruloplasmin (Cp), complement component C3C and one visceral protein, i.e., retinol binding protein (RBP). We found increased plasma concentrations of Hp, alpha 1AT, and Cp in major depressed subjects as compared with healthy controls, with minor depressives exhibiting an intermediate position. RBP was significantly lower in minor and major depressives than in normal controls. The disorders in these proteins were rather sensitive (62%) for major depression, with a specificity equalling 96%. Our findings are compatible with the hypothesis that major depression may be accompanied by inflammatory changes with higher levels of positive APPs (i.e., alpha 1AT, Hp, Cp, alpha 1S) and lower levels of visceral proteins (i.e., RBP, Tf, Alb).

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1573127     DOI: 10.1016/0165-0327(92)90066-f

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  27 in total

1.  Reference distributions for the positive acute phase proteins, alpha1-acid glycoprotein (orosomucoid), alpha1-antitrypsin, and haptoglobin: a comparison of a large cohort to the world's literature.

Authors:  R F Ritchie; G E Palomaki; L M Neveux; O Navolotskaia
Journal:  J Clin Lab Anal       Date:  2000       Impact factor: 2.352

Review 2.  Targeting cyclooxygenase-2 in depression is not a viable therapeutic approach and may even aggravate the pathophysiology underpinning depression.

Authors:  Michael Maes
Journal:  Metab Brain Dis       Date:  2012-07-07       Impact factor: 3.584

Review 3.  New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates--Nrf2 activators and GSK-3 inhibitors.

Authors:  Michael Maes; Zdenĕk Fišar; Miguel Medina; Giovanni Scapagnini; Gabriel Nowak; Michael Berk
Journal:  Inflammopharmacology       Date:  2012-01-24       Impact factor: 4.473

Review 4.  Measurement and analysis of unbound drug concentrations.

Authors:  J D Wright; F D Boudinot; M R Ujhelyi
Journal:  Clin Pharmacokinet       Date:  1996-06       Impact factor: 6.447

Review 5.  Psychoneuroimmunology meets neuropsychopharmacology: translational implications of the impact of inflammation on behavior.

Authors:  Ebrahim Haroon; Charles L Raison; Andrew H Miller
Journal:  Neuropsychopharmacology       Date:  2011-09-14       Impact factor: 7.853

6.  Comorbid depression in heart failure.

Authors:  J Wallenborn; C E Angermann
Journal:  Herz       Date:  2013-09       Impact factor: 1.443

Review 7.  Biological risk factors for late life depression.

Authors:  Henning Tiemeier
Journal:  Eur J Epidemiol       Date:  2003       Impact factor: 8.082

8.  Serum cortisol, immunoglobulins and some complements among depressed patients.

Authors:  Hussein Kadhem Al-Hakeim
Journal:  Indian J Clin Biochem       Date:  2008-03-06

9.  Increased serum tumor necrosis factor-alpha levels and treatment response in major depressive disorder.

Authors:  Cengiz Tuglu; S Hakan Kara; Okan Caliyurt; Erdal Vardar; Ercan Abay
Journal:  Psychopharmacology (Berl)       Date:  2003-08-30       Impact factor: 4.530

10.  Lower Serum Zinc and Higher CRP Strongly Predict Prenatal Depression and Physio-somatic Symptoms, Which All Together Predict Postnatal Depressive Symptoms.

Authors:  Chutima Roomruangwong; Buranee Kanchanatawan; Sunee Sirivichayakul; Boris Mahieu; Gabriel Nowak; Michael Maes
Journal:  Mol Neurobiol       Date:  2016-02-05       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.